Endoplasmic Reticulum-Targeting Near-Infrared Fluorescent Probe for CYP2J2 Activity and Its Imaging Application in

Xiangge Tian1,2,3, Tao Liu4, Mingyue Zhu2

  • 1Department of Pharmacy, Peking University Shenzhen Hospital, Shenzhen 518036, China.

Analytical Chemistry
|June 30, 2022
PubMed

Insights

A new near-infrared fluorescent probe, ER-BnXPI, effectively monitors endoplasmic reticulum (ER) enzyme CYP2J2 activity. This tool aids in understanding ER stress and diagnosing related cancers and cardiovascular diseases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medical Imaging

Background:

  • Cytochrome P450 2J2 (CYP2J2) is crucial for metabolizing polyunsaturated fatty acids.
  • Abnormal CYP2J2 expression is linked to cancer and cardiovascular disease progression.
  • Targeting endoplasmic reticulum (ER) enzyme activity is vital for disease monitoring.

Purpose of the Study:

  • To develop a selective and sensitive probe for monitoring CYP2J2 activity in the ER.
  • To visualize CYP2J2 activity changes under ER stress conditions.
  • To assess the probe's utility in diagnosing CYP2J2-related diseases.

Main Methods:

  • Development of an ER-targeting, near-infrared (NIR) fluorescent probe, ER-BnXPI.
  • Testing probe selectivity and sensitivity against various CYP450 isoforms.
  • Imaging CYP2J2 activity in living cells under ER stress models.
  • In vivo imaging of ER-BnXPI in tumor models.

Main Results:

  • ER-BnXPI demonstrated high selectivity and sensitivity for CYP2J2.
  • The probe showed excellent endoplasmic reticulum localization.
  • CYP2J2 activity variations were successfully imaged in living cells and in vivo tumors.
  • Tumor tissues were clearly distinguished from para-cancerous tissues.

Conclusions:

  • ER-BnXPI is a promising tool for studying CYP2J2 physiological functions.
  • The probe offers a novel approach for diagnosing CYP2J2-related vascular inflammation and cancer.
  • ER-BnXPI facilitates exploration of ER stress mechanisms and disease pathology.